• Home
  • About
  • UPCOMING WEBINARS & SEMINARS
  • Consultation
  • USP 61/62 FAQ
  • Contact

Barry A. Friedman, PhD LLC

FDA Regulatory Compliance for the Pharmaceutical, Biotechnology and Medical Device Arenas

RECALL OF PDI NON-STERILE ALCOHOL WIPES RAISES ADDITIONAL QUESTIONS SAYS MSNBC.COM

October 19, 2011 By Barry Friedman Leave a Comment

FRIEDMAN QUOTED AS SAYING THAT NON-STERILE GAUZE PADS SHOULD NOT BE USED WITH INJECTABLES

COMMENT

 JoNel Aleccia, Health Writer for MSNBC.com, questions the use of non-sterile wipes based upon a massive recall of potentially contaminated alcohol prep products by a second manufacturer.  “Is there any place for a non-sterile alcohol prep pad in a hospital setting?”  Dr. Christine Nyquist, a Colorado infection control director who blew the whistle on dangerous bacteria in alcohol wipes last fall believes “there isn’t.” Until recently, Bacillus cereus was tolerated at very low levels, which were found in the non-sterile PDI products, Melanie Leibowitz, the senior director of regulatory affairs
for PDI Inc, stated.  But the FDA appears to be cracking down on the bacterium in the wake of the H&P Industries crisis.

New recall of alcohol wipes raises larger question:
Dump non-sterile products?

By JoNel
Aleccia
Health writer

msnbc.com

updated 10/10/2011 8:46:40 AM ET

A massive recall of potentially contaminated alcohol prep products by a second manufacturer is raising sharp questions about an entire category of medical supplies: non-sterile pads and swabs, infection experts say.

“Is there any place for a non-sterile alcohol prep pad in a hospital setting?” said Dr. Christine Nyquist, a Colorado infection control director who blew the whistle on dangerous bacteria in alcohol wipes last fall. “We believe there isn’t.”

Nyquist and other microbiology experts say a debate is brewing about whether the non-sterile pads and wipes routinely used in hospitals, clinics and private homes to clean skin before shots and other procedures should be curtailed — or perhaps banned —
because of the potential for infection. While sterile pads have had problems,
too, non-sterile products may raise alarms from the start.

“I don’t believe non-sterile products such as this should be used in a situation where you are using injectables,” said Barry A. Friedman, a microbiologist and sterilization expert
who advises drug and device manufacturers. “I have a feeling what we’re seeing
is the tip of the iceberg.”

Nyquist’s and Friedman’s comments follow the recall last month of nearly 300 million individual non-sterile alcohol prep products manufactured and distributed by Pacific Disposables International Inc. of Orangeburg, N.Y.

The recall, which dates back two years, was initiated because the pads may have been contaminated with Bacillus cereus, a potentially life-threatening bacterium, according to the federal Food and Drug Administration.

A hemophiliac patient reported developing a bacterial infection caused by Bacillus cereus after PDI alcohol prep pads tainted with the germ were used during an infusion, according to an FDA inspection report. The company was urged to recall the products in June, an
FDA official said, but didn’t respond until September.

The PDI recall follows this year’s highly-publicized global recall of hundreds of millions of alcohol and iodine wipes and pads made and sold by the Triad Group and H&P Industries, Inc. of Hartland, Wis.

Bacillus cereus bacteria found in Triad prep products have been blamed for deaths and devastating infections in patients nationwide. Federal officials shut down the firms in June to prevent distribution of tainted medical wipes and other supplies.

Triad and H&P Industries recalled both sterile and non-sterile products, and federal Food and Drug Administration investigators found that the company didn’t validate processes
that should have ensured sterility and prevented other contamination.

In the overall alcohol prep market, about 70 percent of products are sterile, and about 30 percent are non-sterile, estimated Melanie Leibowitz, the senior director of regulatory affairs for PDI Inc.

Current rules from U.S. Pharmacopeia, which sets international standards, prohibit objectionable organisms in non-sterile products if they cause illness or degrade a product’s
effectiveness. Tests for certain organisms, such as Staphylococcus aureus and
E. coli, are required. Until recently, Bacillus cereus was tolerated at very
low levels, which were found in the non-sterile PDI products, Leibowitz said.
But the FDA appears to be cracking down on the bacterium in the wake of the
H&P Industries crisis.

“It is a zero-tolerance program that we’ve been communicated,” she said.

FDA officials wouldn’t comment specifically on the PDI issue or on whether they’re scrutinizing all manufacturers more closely for Bacillus cereus contamination. As it stands now, Bacillus cereus can be considered objectionable depending on the particular product and its use, a spokeswoman said. In a statement, FDA officials said they’re monitoring
and evaluating the use of alcohol prep products.

Earlier this year, FDA issued warnings to health care providers reminding them to be careful about using non-sterile pads in patients with depressed immune systems, before catheter insertions or before surgery. The agency also warned that pads packed in kits with injectable drugs may not be sterile.

That can create confusion for health care workers and home users, who may assume the products are sterile, Nyquist said. In some cases, the pad packaging doesn’t indicate whether it’s sterile or not.

Some hospital infection control experts said they’d wait for FDA or other government agencies to announce any formal changes in policy before deciding whether to continue using non-sterile alcohol pads and wipes.

“Before you make a broad position statement, you want to make sure you have all your evidence,” said Linda Greene, a registered nurse and board member of the Association of Professionals in Infection Control.

But others said they’re acting now. Nyquist was part of the Colorado Children’s Hospital team that detected the connection between unusual Bacillus cereus infections in sick kids and Triad Group alcohol wipes.

“We switched over entirely to sterile prep pads,” said Nyquist, who urged other hospitals in her region to do the same. “It’s consumer beware. Our position is that alcohol prep pads should be sterile.”

© 2011 msnbc.com Reprints

 

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)

Related

Filed Under: FDA Compliance, Recall, Regulatory Compliance Tagged With: alcohol wipes, Aleccia, Bacillus cereus, christine nyquist, friedman, melanie leibowitz, MSNBC.com, non-sterile alcohol wipes, PDI

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

New Reader? Learn More

Connect With Me:

  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Webinar Registration & Information

FREQUENTLY ASKED QUESTIONS:

FDA Form 483 Frequently Asked Questions

USP General Chapter

USP General Chapter 62, Part II

TOP OBSERVATIONS:

FDA’s CDER LISTING OF TOP NINETEEN OBSERVATIONS FOR 2014

FDA CDER Most Frequent Form FDA 483 Observations Fiscal Year 2012

CDER MOST FREQUENTLY CITED DRUG OBSERVATIONS – FISCAL YEAR 2010

Top Posts:

Top Posts for 2012

Top Posts for 2013

Top Posts Year To Date

Recent Posts

  • Upcoming Microbiological Webinars
  • Microbiological Webinars
  • Microbiological Webinars 2020 (Upcoming)
  • General Chapter (USP<60>) on B. cepacia Complex to Issue December 1, 2019
  • Les Produits Chimiques B.G.R., Inc. Receives FDA Warning Letter (07/24/2018) for Failure to Perform Laboratory Testing

Categories

follow us in feedly
  • Home
  • About
  • UPCOMING WEBINARS & SEMINARS
  • Consultation
  • USP 61/62 FAQ
  • Contact
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter

Thank You For Visiting Barry A. Friedman, PhD LLC - 2015

Welcome To My Blog!
Please enter your name and email below to receive my newsletter.
Your information will *never* be shared or sold to a 3rd party.